Supply constraints force pause of BMS, RayzeBio cancer study

Thanks to a shortage of the isotope actinium, RayzeBio has temporarily halted new patient enrollment in its phase 3 study in neuroendocrine tumors.

Related Keywords

Minnesota ,United States ,Switzerland ,Swiss ,Bristol Myers ,Samit Hirawat ,Novarti Lutathera ,William Blair ,Novartis ,Bristol Myers Squibb ,Big Pharma ,San Diego Based ,